Clinical Features of Systemic Lupus Erythematosus

Kelley's Textbook of Rheumatology: Volume 1-2, Ninth Edition

Volumn 2, Issue , 2012, Pages 1283-1303

  Dall'Era, Maria ^a   Wofsy, David ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85167751097     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1738-9.00080-3     Document Type: Chapter

References (253)

1. EM Tan, AS Cohen, JF Fries, et al. (1982) The 1982 revised classification of systemic lupus erythematosus. Arthritis Rheum 11 1271-1277
2. MC Hochberg (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 1725
3. GJ Pons-Estel, GS Alarcon, L Scofield, et al. (2010) Understanding the epidemiology and progession of systemic lupus erythematosus. Semin Arthritis Rheum 39 257-268
4. KM Uramoto, CJ Michet, J Thumboo, et al. (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42 46-50
5. SP Ballou, MA Khan and I Kushner (1982) Clinical features of systemic lupus erythematosus. Arthritis Rheum 25 55-60
6. EF Chakravarty, TM Bush, S Manzi, et al. (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56 2092-2094
7. J Boddaert, DL Huong, Z Amoura, et al. (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83 348-359
8. EL Dubois and DL Tuffanelli (1964) Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. JAMA 190 104-111
9. D Estes and CL Christian (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50 85-95
10. MC Hochberg, RE Boyd, JM Ahearn, et al. (1985) Systemic lupus erythematosus: a review of the clinico-laboratory features and immunopathogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 64 285-295
11. M Pistiner, DJ Wallace, S Nessim, et al. (1991) Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21 55-64
12. C Vitali, W Bencivelli, DA Isenberg, et al. (1992) European Consensus Study Group for Disease Activity in SLE: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol 10 527-539
13. JN Gilliam and RD Sontheimer (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4 471-475
14. RD Sontheimer (1997) The lexicon of cutaneous lupus erythematosus: a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 6 84-95
15. T Watanabe and T Tsuchida (1995) Classification of lupus erythematosus based upon cutaneous manifestations: dermatologic, systemic, and laboratory features in 191 patients. Dermatology 190 277-283
16. JN Gilliam and RD Sontheimer (1982) Skin manifestations of SLE. Clin Rheum Dis 8 207-218
17. SI Chaudhry, LA Murphy and IR White (2005) Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin Exp Dermatol 30 655-658
18. N Parikh, J Choi, M Li, et al. (2010) Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematosus, in a sun-protected area. Lupus 19 210-212
19. C Perniciaro, HW Randle and HO Perry (1995) Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg 21 255-257
20. HW Walling and RD Sontheimer (2009) Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 10 365-381
21. S Vassileva (2004) Bullous systemic lupus erythematosus. Clin Dermatol 22 129-138
22. CJ Sanders, H Van Weelden, GA Kazzaz, et al. (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149 131-137
23. WD Tutrone, CT Spann, N Scheinfeld and VA Deleo (2003) Polymorphic light eruption. Dermatol Ther 16 28-39
24. P Fabbri, L Amato, C Chiarini, et al. (2004) Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. Lupus 13 455-462
25. D Alarcon-Segovia and JA Cetina (1974) Lupus hair. Am J Med Sci 267 241-242
26. MM Nico, MA Vilela, EA Rivitti and SV Lourenço (2008) Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol 18 376-381
27. R Jonsson, G Heyden, NG Westberg and G Nyberg (1984) Oral mucosal lesions in systemic lupus erythematosus—a clinical, histopathological and immunopathological study. J Rheumatol 11 38-42
28. KM David-Bajar and BM Davis (1997) Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6 145-157
29. JM Grossman (2009) Lupus arthritis. Best Pract Res Clin Rheumatol 23 495-506
30. R Labowitz and HR Schumacher (1971) Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74 911-921
31. KD Morley, A Leung and RI Rynes (1982) Lupus foot. Br Med J 284 557-558
32. MT Chan, P Owen, J Dunphy, et al. (2008) Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 35 77-83
33. B Ostendorf, A Scherer, C Specker, et al. (2003) Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 48 157-165
34. N Boutry, E Hachulla, RM Flipo, et al. (2005) MR imaging findings in hands in early rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary Sjögren syndrome. Radiology 236 593-600
35. BN Weissman, AS Rappoport, JL Sosman and PH Schur (1978) Radiographic findings in the hands in patients with systemic lupus erythematosus. Radiology 126 313-317
36. RH Leskinen, BV Skrifvars, LS Laasonen and KJ Edgren (1984) Bone lesions in systemic lupus erythematosus. Radiology 153 349-352
37. EL Dubois and L Cozen (1960) Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174 966-971
38. K Nagasawa, Y Tada, S Koarada, et al. (2005) Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 14 385-390
39. K Oinuma, Y Harada, Y Nawata, et al. (2001) Osteonecrosis in patients with systemic lupus erythematosus develops early after starting high dose corticosteroid treatment. Ann Rheum Dis 60 1145-1148
40. SC Fialho, E Bonfa, LF Vitule, et al. (2007) Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus 16 239-244
41. J Calvo-Alén, G McGwin, S Toloza, et al. (2006) LUMINA Study Group: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis 65 785-790
42. GC Tsokos, HM Moutsopoulos and AD Steinberg (1981) Muscle involvement in systemic lupus erythematosus. JAMA 246 766-768
43. KL Lim, R Abdul-Wahab, J Lowe and RJ Powell (1994) Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis 53 178-182
44. MI Danila, GJ Pons-Estel, J Zhang, et al. (2009) Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford) 48 542-545
45. HA Austin 3rd, DT Boumpas, EM Vaughan and JE Balow (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45 544-550
46. E Descombes, D Droz, L Drouet, et al. (1997) Renal vascular lesions in lupus nephritis. Medicine 76 355-368
47. GB Appel, CL Pirani and V D’Agati (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 1499-1515
48. G Banfi, T Bertani, V Boeri, et al. (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18 240-248
49. E Baranowska-Daca, YJ Choi, R Barrios, et al. (2001) Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol 32 1125-1135
50. HA Austin (1998) Clinical evaluation and monitoring of lupus kidney disease. Lupus 7 618-621
51. WF Keane (2005) Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 35(4 Suppl 1), S97-S105
52. DJ Birmingham, BH Rovin, G Shidham, et al. (2007) Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int 72 865-870
53. JM Ginsberg, BS Chang, RA Matarese and S Garella (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309 1543-1546
54. DM Fine, M Ziegenbein, M Petri, et al. (2009) A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int 76 1284-1288
55. JP Grande and JE Balow (1998) Renal biopsy in lupus nephritis. Lupus 7 611-617
56. JJ Weening, VD D’Agati, MM Schwartz, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 241-250
57. AR Eiser, SM Katz and C Swartz (1979) Clinically occult diffuse proliferative lupus nephritis: an age-related phenomenon. Arch Intern Med 139 1022-1025
58. S Jacobsen, H Starklint, J Petersen, et al. (1999) Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28 288-299
59. JT Good Jr, TE King, VB Antony and SA Sahn (1983) Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 84 714-718
60. GS Breuer, M Deeb, D Fisher and G Nesher (2005) Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 34 744-749
61. BL Man and CC Mok (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14 822-826
62. EJ ter Borg, G Horst, PC Limburg, et al. (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17 1642-1648
63. HM Haupt, GW Moore and GM Hutchins (1981) The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med 71 791-798
64. RA Matthay, MI Schwarz, TL Petty, et al. (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine 54 397-409
65. DJ Todd and KH Costenbader (2009) Dyspnea in a young woman with active systemic lupus erythematosus. Lupus 18 777-784
66. BI Hoffbrand and ER Beck (1965) Unexplained dyspnea and shrinking lungs in systemic lupus erythematosus. Br Med J 1 1273-1277
67. AP Andonopoulos, SH Constantopoulos, V Galanopoulou, et al. (1988) Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest 94 312-315
68. IG Crozier, E Li, MJ Milne and MG Nicholls (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65 1145-1148
69. BH Bulkley and WC Roberts (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 58 243-264
70. CA Roldan, BK Shively and MH Crawford (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335 1424-1430
71. AK Bidani, JL Roberts, MM Schwartz and EJ Lewis (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69 849-858
72. CA Roldan, CR Qualls, KS Sopko and WL Sibbitt Jr (2008) Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 35 224-229
73. CA Roldan, EA Gelgand, CR Qualls and WL Sibbitt Jr (2007) Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology 108 331-337
74. MB Urowitz, AA Bookman, BE Koehler, et al. (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60 221-225
75. YS Haider and WC Roberts (1981) Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 70 775-781
76. S Manzi, EN Meilahn, JE Rairie, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145 408-415
77. MB Urowitz, D Gladman, D Ibanez, et al. (1995) Systemic Lupus International Collaborating Clinics: Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res 62 881-887
78. JM Esdaile, M Abrahamowicz, T Grodzicky, et al. (1991) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 2331-2337
79. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 599-608
80. FB Karassa, A Afeltra, A Ambrozic, et al. (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54 312-324
81. N Futrell, LR Schultz and C Millikan (1992) Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42 1649-1657
82. ES Molloy and LH Calabrese (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60 3761-3765
83. WL Sibbitt Jr, WM Brooks, M Kornfeld, et al. (2010) Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 40 32-52
84. DD Mitsikostas, PP Sfikakis and PJ Goadsby (2004) A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127(Pt 5), 1200-1209
85. YC Lin, AG Wang and MY Yen (2009) Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol 87 204-210
86. S Ferreira, DP D’Cruz and GR Hughes (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44 434-439
87. E Krishnan (2005) Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med 118 1415.e1-1415.e7
88. SM Sultan, Y Ioannou and DA Isenberg (1999) A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 38 917-932
89. BI Hoffman and WA Katz (1980) The gastrointestinal manifestations of systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum 9 237-247
90. JC Reynolds, RD Inman, RP Kimberly, et al. (1982) Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature. Medicine 61 25-32
91. G Nesher, GS Breuer, K Temprano, et al. (2006) Lupus-associated pancreatitis. Semin Arthritis Rheum 35 260-267
92. SF Ko, TY Lee, TT Cheng, et al. (1997) CT findings at lupus mesenteric vasculitis. Acta Radiol 38 115-120
93. BA Runyon, DR LaBrecque and S Anuras (1980) The spectrum of liver disease in systemic lupus erythematosus: report of 33 histologically-proved cases and review of the literature. Am J Med 69 187-194
94. WI Youssef and AS Tavill (2002) Connective tissue diseases and the liver. J Clin Gastroenterol 35 345-349
95. JB Davies and PK Rao (2008) Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 19 512-518
96. O Ushiyama, K Ushiyama, S Koarada, et al. (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59 705-708
97. KY Fong, S Loizou, ML Boey and MJ Walport (1992) Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 31 453-455
98. M Delezé, D Alarcón-Segovia, CV Oria, et al. (1989) Hemocytopenia in systemic lupus erythematosus: relationship to antiphospholipid antibodies. J Rheumatol 16 926-930
99. SJ Rivero, E Díaz-Jouanen and D Alarcón-Segovia (1978) Lymphopenia in systemic lupus erythematosus: clinical, diagnostic, and prognostic significance. Arthritis Rheum 21 295-305
100. JB Winfield, RJ Winchester and HG Kunkel (1975) Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum 18 587-594
101. Y Rabinowitz and W Dameshek (1960) Systemic lupus erythematosus after “idiopathic” thrombocytopenic purpura: a review. Ann Intern Med 52 1-28
102. M Kojima, S Nakamura, Y Morishita, et al. (2000) Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 50 304-312
103. A Kavanaugh, R Tomar, J Reveille, et al. (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124 71-81
104. EM Tan, TE Feltkamp, JS Smolen, et al. (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40 1601-1611
105. PJ Maddison, TT Provost and M Reichlin (1981) Serologic findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine 60 87-94
106. GC Sharp, WS Irvin, EM Tan, et al. (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52 148-159
107. RM Watson, AT Lane, NK Barnett, et al. (1984) Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature. Medicine 63 362-378
108. DP McCauliffe (1995) Neonatal lupus erythematosus: a transplacentally acquired autoimmune disorder. Semin Dermatol 14 47-53
109. KM David-Bajar, SD Bennion, JD DeSpain, et al. (1992) Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99 251-257
110. JM Singer (1961) The latex fixation test in rheumatic diseases. Am J Med 31 766-779
111. W Lloyd and PH Schur (1981) Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 60 208-217
112. AJG Swaak, J Gorenwold and W Bronsveld (1986) Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45 359-366
113. M Kirschfink, F Petry, K Khirwadkar, et al. (1993) Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin Exp Immunol 94 267-272
114. V Agnello (1978) Complement deficiency states. Medicine 57 1-24
115. G Sturfelt, L Truedsson, H Johansen, et al. (1990) Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet 38 427-433
116. C-E Tseng, JP Buyon, M Kim, et al. (2006) The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54 3623-3632
117. PM Izmirly, TL Rivera and JP Buyon (2007) Neonatal lupus syndromes. Rheum Dis Clin N Am 33 267-285
118. R Cimaz, DL Spence, L Hornberger and ED Silverman (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142 678-683
119. E Silverman and E Jaeggi (2010) Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 72 223-225
120. EM Tan, AS Cohen, JF Fries, et al. (1982) The 1982 revised classification of systemic lupus erythematosus. Arthritis Rheum 11 1271-1277
121. MC Hochberg (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 1725
122. GJ Pons-Estel, GS Alarcon, L Scofield, et al. (2010) Understanding the epidemiology and progession of systemic lupus erythematosus. Semin Arthritis Rheum 39 257-268
123. KM Uramoto, CJ Michet, J Thumboo, et al. (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42 46-50
124. SP Ballou, MA Khan and I Kushner (1982) Clinical features of systemic lupus erythematosus. Arthritis Rheum 25 55-60
125. EF Chakravarty, TM Bush, S Manzi, et al. (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56 2092-2094
126. J Boddaert, DL Huong, Z Amoura, et al. (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83 348-359
127. EL Dubois and DL Tuffanelli (1964) Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. JAMA 190 104-111
128. D Estes and CL Christian (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50 85-95
129. MC Hochberg, RE Boyd, JM Ahearn, et al. (1985) Systemic lupus erythematosus: a review of the clinico-laboratory features and immunopathogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 64 285-295
130. M Pistiner, DJ Wallace, S Nessim, et al. (1991) Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21 55-64
131. C Vitali, W Bencivelli, DA Isenberg, et al. (1992) European Consensus Study Group for Disease Activity in SLE: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol 10 527-539
132. JN Gilliam and RD Sontheimer (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4 471-475
133. RD Sontheimer (1997) The lexicon of cutaneous lupus erythematosus: a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 6 84-95
134. T Watanabe and T Tsuchida (1995) Classification of lupus erythematosus based upon cutaneous manifestations: dermatologic, systemic, and laboratory features in 191 patients. Dermatology 190 277-283
135. GK Perera, MM Black and DH McGibbon (2004) Bullous subacute cutaneous lupus erythematosus. Clin Exp Dermatol 29 265-267
136. JN Gilliam and RD Sontheimer (1982) Skin manifestations of SLE. Clin Rheum Dis 8 207-218
137. SI Chaudhry, LA Murphy and IR White (2005) Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin Exp Dermatol 30 655-658
138. N Parikh, J Choi, M Li, et al. (2010) Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematosus, in a sun-protected area. Lupus 19 210-212
139. C Perniciaro, HW Randle and HO Perry (1995) Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg 21 255-257
140. HW Walling and RD Sontheimer (2009) Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 10 365-381
141. S Vassileva (2004) Bullous systemic lupus erythematosus. Clin Dermatol 22 129-138
142. CJ Sanders, H Van Weelden, GA Kazzaz, et al. (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149 131-137
143. WD Tutrone, CT Spann, N Scheinfeld and VA Deleo (2003) Polymorphic light eruption. Dermatol Ther 16 28-39
144. P Fabbri, L Amato, C Chiarini, et al. (2004) Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. Lupus 13 455-462
145. D Alarcon-Segovia and JA Cetina (1974) Lupus hair. Am J Med Sci 267 241-242
146. VP Werth, WL White, MR Sanchez and AG Franks (1992) Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 128 368-371
147. MM Nico, MA Vilela, EA Rivitti and SV Lourenço (2008) Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol 18 376-381
148. R Jonsson, G Heyden, NG Westberg and G Nyberg (1984) Oral mucosal lesions in systemic lupus erythematosus—a clinical, histopathological and immunopathological study. J Rheumatol 11 38-42
149. KM David-Bajar and BM Davis (1997) Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6 145-157
150. VC Fabré, S Lear, M Reichlin, et al. (1991) Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol 127 1006-1011
151. JM Grossman (2009) Lupus arthritis. Best Pract Res Clin Rheumatol 23 495-506
152. R Labowitz and HR Schumacher (1971) Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74 911-921
153. KD Morley, A Leung and RI Rynes (1982) Lupus foot. Br Med J 284 557-558
154. MT Chan, P Owen, J Dunphy, et al. (2008) Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 35 77-83
155. B Ostendorf, A Scherer, C Specker, et al. (2003) Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 48 157-165
156. N Boutry, E Hachulla, RM Flipo, et al. (2005) MR imaging findings in hands in early rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary Sjögren syndrome. Radiology 236 593-600
157. DL Goldenberg and AS Cohen (1978) Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine 57 239-252
158. BN Weissman, AS Rappoport, JL Sosman and PH Schur (1978) Radiographic findings in the hands in patients with systemic lupus erythematosus. Radiology 126 313-317
159. RH Leskinen, BV Skrifvars, LS Laasonen and KJ Edgren (1984) Bone lesions in systemic lupus erythematosus. Radiology 153 349-352
160. EL Dubois and L Cozen (1960) Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174 966-971
161. K Nagasawa, Y Tada, S Koarada, et al. (2005) Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 14 385-390
162. K Oinuma, Y Harada, Y Nawata, et al. (2001) Osteonecrosis in patients with systemic lupus erythematosus develops early after starting high dose corticosteroid treatment. Ann Rheum Dis 60 1145-1148
163. SC Fialho, E Bonfa, LF Vitule, et al. (2007) Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus 16 239-244
164. J Calvo-Alén, G McGwin, S Toloza, et al. (2006) LUMINA Study Group: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis 65 785-790
165. GC Tsokos, HM Moutsopoulos and AD Steinberg (1981) Muscle involvement in systemic lupus erythematosus. JAMA 246 766-768
166. KL Lim, R Abdul-Wahab, J Lowe and RJ Powell (1994) Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis 53 178-182
167. MI Danila, GJ Pons-Estel, J Zhang, et al. (2009) Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology 48 542-545
168. JR Brentjens, M Sepulveda, T Baliah, et al. (1975) Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7 342-350
169. HA Austin 3rd, DT Boumpas, EM Vaughan and JE Balow (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45 544-550
170. E Descombes, D Droz, L Drouet, et al. (1997) Renal vascular lesions in lupus nephritis. Medicine 76 355-368
171. GB Appel, CL Pirani and V D’Agati (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 1499-1515
172. G Banfi, T Bertani, V Boeri, et al. (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18 240-248
173. E Baranowska-Daca, YJ Choi, R Barrios, et al. (2001) Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol 32 1125-1135
174. HA Austin (1998) Clinical evaluation and monitoring of lupus kidney disease. Lupus 7 618-621
175. WF Keane (2005) Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 35(4 Suppl 1), S97-S105
176. DJ Birmingham, BH Rovin, G Shidham, et al. (2007) Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int 72 865-870
177. JM Ginsberg, BS Chang, RA Matarese and S Garella (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309 1543-1546
178. DM Fine, M Ziegenbein, M Petri, et al. (2009) A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int 76 1284-1288
179. JP Grande and JE Balow (1998) Renal biopsy in lupus nephritis. Lupus 7 611-617
180. JJ Weening, VD D’Agati, MM Schwartz, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 241-250
181. AR Eiser, SM Katz and C Swartz (1979) Clinically occult diffuse proliferative lupus nephritis: an age-related phenomenon. Arch Intern Med 139 1022-1025
182. S Jacobsen, H Starklint, J Petersen, et al. (1999) Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28 288-299
183. JT Good Jr, TE King, VB Antony and SA Sahn (1983) Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 84 714-718
184. GS Breuer, M Deeb, D Fisher and G Nesher (2005) Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 34 744-749
185. BL Man and CC Mok (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14 822-826
186. EJ ter Borg, G Horst, PC Limburg, et al. (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17 1642-1648
187. HM Haupt, GW Moore and GM Hutchins (1981) The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med 71 791-798
188. T Inoue, Y Kanayama, A Ohe, et al. (1979) Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann Intern Med 91 30-34
189. RA Matthay, MI Schwarz, TL Petty, et al. (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine 54 397-409
190. DJ Todd and KH Costenbader (2009) Dyspnea in a young woman with active systemic lupus erythematosus. Lupus 18 777-784
191. BI Hoffbrand and ER Beck (1965) Unexplained dyspnea and shrinking lungs in systemic lupus erythematosus. Br Med J 1 1273-1277
192. MY Karim, LC Miranda, CM Tench, et al. (2002) Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 31 289-298
193. AP Andonopoulos, SH Constantopoulos, V Galanopoulou, et al. (1988) Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest 94 312-315
194. RB Gammon, TA Bridges, H al-Nezir, et al. (1992) Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 102 1171-1174
195. IG Crozier, E Li, MJ Milne and MG Nicholls (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65 1145-1148
196. BH Bulkley and WC Roberts (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 58 243-264
197. CA Roldan, BK Shively and MH Crawford (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335 1424-1430
198. AK Bidani, JL Roberts, MM Schwartz and EJ Lewis (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69 849-858
199. CA Roldan, CR Qualls, KS Sopko and WL Sibbitt Jr (2008) Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 35 224-229
200. CA Roldan, EA Gelgand, CR Qualls and WL Sibbitt Jr (2007) Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology 108 331-337
201. MB Urowitz, AA Bookman, BE Koehler, et al. (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60 221-225
202. YS Haider and WC Roberts (1981) Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 70 775-781
203. S Manzi, EN Meilahn, JE Rairie, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145 408-415
204. MB Urowitz, D Gladman, D Ibanez, et al. (1995) Systemic Lupus International Collaborating Clinics: Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res 62 881-887
205. JM Esdaile, M Abrahamowicz, T Grodzicky, et al. (1991) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 2331-2337
206. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 599-608
207. FB Karassa, A Afeltra, A Ambrozic, et al. (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54 312-324
208. N Futrell, LR Schultz and C Millikan (1992) Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42 1649-1657
209. ES Molloy and LH Calabrese (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60 3761-3765
210. WL Sibbitt Jr, WM Brooks, M Kornfeld, et al. (2010) Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 40 32-52
211. DD Mitsikostas, PP Sfikakis and PJ Goadsby (2004) A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127(Pt 5), 1200-1209
212. YC Lin, AG Wang and MY Yen (2009) Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol 87 204-210
213. JF Rizzo 3rd and S Lessell (1991) Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles. Arch Ophthalmol 109 1668-1672
214. S Ferreira, DP D’Cruz and GR Hughes (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44 434-439
215. DM Wingerchuck, VA Lennon, SJ Pittock, et al. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66 1485-1489
216. E Krishnan (2005) Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med 118 1415.e1-1415.e7
217. SM Sultan, Y Ioannou and DA Isenberg (1999) A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 38 917-932
218. G Lapadula, P Muolo, F Semeraro, et al. (1993) Esophageal motility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol 12 515-521
219. BI Hoffman and WA Katz (1980) The gastrointestinal manifestations of systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum 9 237-247
220. JC Reynolds, RD Inman, RP Kimberly, et al. (1982) Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature. Medicine 61 25-32
221. G Nesher, GS Breuer, K Temprano, et al. (2006) Lupus-associated pancreatitis. Semin Arthritis Rheum 35 260-267
222. SF Ko, TY Lee, TT Cheng, et al. (1997) CT findings at lupus mesenteric vasculitis. Acta Radiol 38 115-120
223. BA Runyon, DR LaBrecque and S Anuras (1980) The spectrum of liver disease in systemic lupus erythematosus: report of 33 histologically-proved cases and review of the literature. Am J Med 69 187-194
224. WI Youssef and AS Tavill (2002) Connective tissue diseases and the liver. J Clin Gastroenterol 35 345-349
225. RM Morlà, M Ramos-Casals, M García-Carrasco, et al. (1999) Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 8 160-163
226. G Perlemuter, S Chaussade, B Wechsler, et al. (1998) Chronic intestinal pseudo-obstruction in systemic lupus erythematosus. Gut 43 117-122
227. JB Davies and PK Rao (2008) Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 19 512-518
228. O Ushiyama, K Ushiyama, S Koarada, et al. (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59 705-708
229. KY Fong, S Loizou, ML Boey and MJ Walport (1992) Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 31 453-455
230. M Delezé, D Alarcón-Segovia, CV Oria, et al. (1989) Hemocytopenia in systemic lupus erythematosus: relationship to antiphospholipid antibodies. J Rheumatol 16 926-930
231. SJ Rivero, E Díaz-Jouanen and D Alarcón-Segovia (1978) Lymphopenia in systemic lupus erythematosus: clinical, diagnostic, and prognostic significance. Arthritis Rheum 21 295-305
232. JB Winfield, RJ Winchester and HG Kunkel (1975) Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum 18 587-594
233. W Füreder, U Firbas, JL Nichol, et al. (2002) Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus. Lupus 11 221-226
234. Y Rabinowitz and W Dameshek (1960) Systemic lupus erythematosus after “idiopathic” thrombocytopenic purpura: a review. Ann Intern Med 52 1-28
235. M Kojima, S Nakamura, Y Morishita, et al. (2000) Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 50 304-312
236. P Piliero and R Furie (1990) Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 20 185-189
237. A Kavanaugh, R Tomar, J Reveille, et al. (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124 71-81
238. EM Tan, TE Feltkamp, JS Smolen, et al. (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40 1601-1611
239. PJ Maddison, TT Provost and M Reichlin (1981) Serologic findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine 60 87-94
240. GC Sharp, WS Irvin, EM Tan, et al. (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52 148-159
241. RM Watson, AT Lane, NK Barnett, et al. (1984) Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature. Medicine 63 362-378
242. DP McCauliffe (1995) Neonatal lupus erythematosus: a transplacentally acquired autoimmune disorder. Semin Dermatol 14 47-53
243. KM David-Bajar, SD Bennion, JD DeSpain, et al. (1992) Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99 251-257
244. JM Singer (1961) The latex fixation test in rheumatic diseases. Am J Med 31 766-779
245. W Lloyd and PH Schur (1981) Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 60 208-217
246. AJG Swaak, J Gorenwold and W Bronsveld (1986) Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45 359-366
247. M Kirschfink, F Petry, K Khirwadkar, et al. (1993) Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin Exp Immunol 94 267-272
248. V Agnello (1978) Complement deficiency states. Medicine 57 1-24
249. G Sturfelt, L Truedsson, H Johansen, et al. (1990) Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet 38 427-433
250. C-E Tseng, JP Buyon, M Kim, et al. (2006) The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54 3623-3632
251. PM Izmirly, TL Rivera and JP Buyon (2007) Neonatal lupus syndromes. Rheum Dis Clin N Am 33 267-285
252. R Cimaz, DL Spence, L Hornberger and ED Silverman (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142 678-683
253. E Silverman and E Jaeggi (2010) Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 72 223-225